Related Experiment Video
Updated: May 10, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Deciphering Multidrug-Resistant Pseudomonas aeruginosa: Mechanistic Insights and Environmental Risks
Yang Pei1,2,3, Péter Hamar4, De-Sheng Pei1
1School of Public Health, Chongqing Medical University, Chongqing 400016, China.
Abstract:
The rise of multidrug-resistant (MDR) Pseudomonas aeruginosa (P. aeruginosa) presents a significant challenge to clinical treatment and environmental risks. This review delves into the complex mechanisms underlying MDR development in P. aeruginosa, such as genetic mutations, horizontal gene transfer (HGT), and the interaction between virulence factors and resistance genes. It evaluates current detection methods, from traditional bacteriology to advanced molecular techniques, emphasizing the need for rapid and accurate diagnostics. This review also examines therapeutic strategies, including broad-spectrum antibiotics, novel drug candidates, combination therapies, and innovative approaches like RNA interference, CRISPR-Cas9 gene editing, and bridge RNA-guided gene editing. Importantly, this review highlights the distribution, migration, and environmental risks of MDR P. aeruginosa, underscoring its adaptability to diverse environments. It concludes by stressing the necessity for continued research and development in antimicrobial resistance, advocating for an integrated approach that combines genomics, clinical practice, and environmental considerations to devise innovative solutions and preserve antibiotic efficacy.
Insights
Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) poses clinical and environmental threats. This review explores resistance mechanisms, detection, and novel therapies, emphasizing integrated solutions for antimicrobial resistance.
Area of Science:
- Microbiology
- Genetics
- Environmental Science
Background:
- Multidrug-resistant (MDR) *Pseudomonas aeruginosa* (*P. aeruginosa*) is a growing clinical and environmental concern.
- Understanding the mechanisms of MDR development is crucial for effective treatment and control.
Purpose of the Study:
- To review the mechanisms of MDR development in *P. aeruginosa*.
- To evaluate current and emerging detection and therapeutic strategies.
- To highlight the environmental risks and adaptability of MDR *P. aeruginosa*.
Main Methods:
- Literature review of genetic mutations, horizontal gene transfer (HGT), and virulence factors.
- Evaluation of traditional and molecular diagnostic techniques.
- Analysis of existing and novel therapeutic interventions, including gene editing technologies.
Main Results:
- MDR development involves genetic mutations, HGT, and gene-virulence factor interactions.
- Rapid and accurate diagnostics are essential.
- Innovative therapies like RNA interference and CRISPR-Cas9 show promise.
- MDR *P. aeruginosa* exhibits significant environmental distribution and adaptability.
Conclusions:
- An integrated approach combining genomics, clinical practice, and environmental monitoring is necessary.
- Continued research and development are vital to combat antimicrobial resistance.
- Preserving antibiotic efficacy requires multifaceted strategies against MDR *P. aeruginosa*.
More Related Videos
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Treatment Resistant Cancers
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...